Copyright
©2011 Baishideng Publishing Group Co.
World J Stem Cells. May 26, 2011; 3(5): 43-52
Published online May 26, 2011. doi: 10.4252/wjsc.v3.i5.43
Published online May 26, 2011. doi: 10.4252/wjsc.v3.i5.43
Tube | C solution(EU/mL) | D solution | Ending concentration | × (lg Ending con) | |||
0.25 | 0.125 | 0.063 | 0.032 | ||||
1 | + | + | - | - | - | 0.125 | -0.9208 |
2 | + | + | - | - | - | 0.125 | -0.9208 |
3 | + | + | + | - | - | 0.060 | -1.2000 |
4 | + | + | - | - | - | 0.125 | -0.9208 |
TAL (0.125EU/mL) | Bacterial endotoxin concentration (EU/mL) | Negative control | E (EU/mL) | |||
0.25 | 0.125 | 0.063 | 0.032 | |||
A solution | + + | + + | - - | - - | - - | 0.125 |
B solution | + + | - - | - - | - - | - - | 0.25 |
C solution | + + | - - | - - | - - | - - | 0.25 |
Group | Result | |
A solution | - | - |
B solution | + | + |
C solution | + | + |
D solution | - | - |
- Citation: Guo CJ, Gao Y, Hou D, Shi DY, Tong XM, Shen D, Xi YM, Wang JF. Preclinical transplantation and safety of HS/PCs expanded from human umbilical cord blood. World J Stem Cells 2011; 3(5): 43-52
- URL: https://www.wjgnet.com/1948-0210/full/v3/i5/43.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v3.i5.43